Molecular Formula | C207H308N56O58S1
|
Molar Mass | 4541.07 |
Solubility | H2O: 1mg/mL, clear, colorless |
Appearance | Solid |
Storage Condition | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
MDL | MFCD00145721 |
Physical and Chemical Properties | Off-white powder with extra odor. |
Use | It can be used to produce adrenocorticotropic hormone (ACTH) and activin. In the production of veterinary drugs, it can be used for the production of luteinizing hormone and follicle-stimulating hormone. |
In vitro study | Adrenocorticotropic Hormone (ACTH) (1-39), human (ACTH 1-39), a member of the melanocortin family, stimulates production of CS by the adrenals, but melanocortin receptors are also found in the central nervous system (CNS) and on immune cells. ACTH 1-39 protects neurons in vitro from several apoptotic, excitotoxic and inflammation-related insults. The conditioned medium (CM) is prepared from untreated astroglia (AS) cultures and from AS cultures treated with 200 nM ACTH 1-39 for 24 h, washed to remove ACTH 1-39, then incubated for another 24 h in DMEM. In initial experiments, no difference is found in oligodendroglia (OL) viability in the presence of OL definedmediumwith 2% newborn calf serum (NCS) or AS CM (prepared in DMEM with no serum). After 24 h, OL death under each condition varies between 1 and 4%. Similar results for OL viability are obtained with microglia (MG) CM. In subsequent experiments, controls in each experiment consist of OL in defined medium with 2% NCS. |